Meridian Bioscience reported $111.23M in Sales Revenues for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbott ABT:US $ 11895M 427M
Accelerate Diagnostics AXDX:US 2.96M 385K
Atrion ATRI:US 40.29M 2.56M
Becton, Dickinson and BDX:US $ 5011M 16M
Bio Rad Laboratories BIO:US $ 700.06M 32.71M
Cerus CERS:US $ 43.02M 7.07M
Meridian Bioscience VIVO:US $ 111.23M 22.89M
Myriad Genetics MYGN:US $ 164.9M 4.1M
Orasure Technologies OSUR:US $ 67.71M 4.14M
Quidel QDEL:US $ 1002.26M 365.39M
Sientra SIEN:US $ 21.4M 1.25M
Staar Surgical STAA:US $ 63.2M 4.2M
Thermo Fisher Scientific TMO:US $ 11818M 1116M
Trinity Biotech TRIB:US $ 18.78M 0.75M
Utah Medical Products UTMD:US $ 12.57M 1.61M